Ronald Reagan UCLA Medical Center (Radiological Sciences) ( Site 0007) — Los Angeles, California

Ronald Reagan UCLA Medical Center (Radiological Sciences) ( Site 0007) is a clinical research site located in Los Angeles, California, United States 90095.

Crixeo Clinical Trials Trust Score: 4/100 (FAILING). This profile has not yet been claimed by the site owner.

Ronald Reagan UCLA Medical Center (Radiological Sciences) ( Site 0007) has participated in 1 clinical trials.

Therapeutic areas: Hodgkin Disease, Lymphoma, Non-Hodgkin, Lymphoma, B-Cell.

Sponsors: Merck Sharp & Dohme LLC.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Los Angeles

Browse all research sites in California · View every site in Los Angeles

Sponsor Feasibility Report

Trust Score: 4/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Ronald Reagan UCLA Medical Center (Radiological Sciences) ( Site 0007)?

Ronald Reagan UCLA Medical Center (Radiological Sciences) ( Site 0007) has a Crixeo Trust Score of 4/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Ronald Reagan UCLA Medical Center (Radiological Sciences) ( Site 0007) conducted?

Ronald Reagan UCLA Medical Center (Radiological Sciences) ( Site 0007) has 1 clinical trials on record. Their work covers Hodgkin Disease, Lymphoma, Non-Hodgkin, Lymphoma, B-Cell.

Is Ronald Reagan UCLA Medical Center (Radiological Sciences) ( Site 0007) accredited by Crixeo Clinical Trials?

Ronald Reagan UCLA Medical Center (Radiological Sciences) ( Site 0007) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Ronald Reagan UCLA Medical Center (Radiological Sciences) ( Site 0007)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.